Boehringer Ingelheim has signed up to become a silver partner of the World Small Animal Veterinary Association (WSAVA).

The company will support the work of the association’s Global Pain Council (GPC) and Oncology Working Group (OWG).

Dr Erich Schoett, Head of Global Marketing Pet Therapeutics and Vaccines at Boehringer Ingelheim, said pet ownership is on the rise, and many people consider their animal companions to be part of the family, and as such, they have high expectations of their veterinarians.

“At the same time, small animal medicine is advancing at a staggering pace. Veterinarians face a continuous need to upskill, adapt to new standards of care and to provide tailored health offerings at each stage of a pet’s life.”

The GPC, chaired jointly by Dr Jo Murrell and Dr Paulo Steagall, aims to create a global environment for companion animals in which pain is considered as the fourth vital sign and addressed appropriately.

The OWG, chaired by Dr Ann Hohenhaus, is working to overcome regional disparities in the treatment of cancers in dogs and cats by providing continuing education (CE) and a range of additional resources, including fact sheets and an Oncology Glossary, to secure advances in the understanding and treatment of oncology globally.

Dr Ellen van Nierop, President of WSAVA, said they are absolutely delighted to welcome Boehringer Ingelheim as a Silver Partner and thank them very much for their support. 

“It’s thanks to the support of our industry partners that we are able to deliver such a wide range of CE to our members and to campaign on the global stage on issues that concern them, such as the global inequity in access to veterinary medicines.”

To stay up to date on the latest industry headlines, sign up to the Pet Industry News e-newsletter.